Nasdaq
CGEM
Cullinan Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +1.9%
- 1 month
- −1.2%
- 1 year
- +128%
$17.95 · Mkt cap $1.10B
At the 6 Aug 2026 close
Nasdaq
Cullinan Therapeutics, Inc.
$17.95 · Mkt cap $1.10B
At the 6 Aug 2026 close
Cullinan Therapeutics, Inc. trades under the ticker CGEM on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $1.10B. The last closing price was $17.95, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +128%, and −1.2% over the past month. Returns are price returns and exclude dividends.
This page exists because CGEM is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.